Mutares has completed the acquisition of Alcura France from Alliance Healthcare Group France

• Strategic development in the healthcare industry
• New platform investment to strengthen the Goods & Services segment
• Distribution and rental of home care equipment and solutions in France

Munich, December 18, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has completed the acquisition of Alcura France from Alliance Healthcare Group France. The company is headquartered in Châteauroux, France, and is a specialised distributor of home care solutions.

Established in 1973, Alcura France is a key player in the distribution of home care solutions in France, servicing a diversified customer base of more than 8,000 active customers. The company is specialized in providing medical equipment to seniors, individuals with disabilities, and other patients, and has distinguished itself through a wide offering of products, encompassing more than 3,000 referenced products, from medical beds to breast pumps and wheelchairs. With a workforce of approx. 500 professionals with proven medical expertise, distributed across 43 agencies in France, Alcura France generated revenues of around EUR 60 million in 2023.

Company profile of Mutares SE & Co. KGaA

Mutares SE & Co. KGaA, Munich (www.mutares.com), a listed private equity holding company with offices in Munich (HQ), Amsterdam, Bad Wiessee, Chicago, Frankfurt, Helsinki, London, Madrid, Milan, Mumbai, Paris, Shanghai, Stockholm, Vienna and Warsaw, acquires companies in special situations which show significant operational improvement potential and are sold again after undergoing a repositioning and stabilization process. For the fiscal year 2024, consolidated revenues of EUR 5.7 billion to EUR 6.3 billion are expected. Based on this, consolidated revenues are to be expanded to approx. EUR 7 billion by 2025 and EUR 10 billion by 2028. As the portfolio grows, so do consulting revenues, which together with portfolio dividends and exit proceeds accrue to the Mutares Holding. On this basis, the Holding Company is expected to generate a net income of EUR 108 million to EUR 132 million for the fiscal year 2024, EUR 125 million to EUR 150 million for the fiscal year 2025 and EUR 200 million for the fiscal year 2028. The Management Board and Supervisory Board together hold more than one-third of all Mutares shares with voting rights. The shares of Mutares SE & Co. KGaA are traded on the Regulated Market of the Frankfurt Stock Exchange under the symbol "MUX" (ISIN: DE000A2NB650) and have been part of the selection index SDAX since December 2023.

For more information, please contact:

Mutares SE & Co. KGaA
Investor Relations
Phone: +49 89 9292 7760
E-mail: ir@mutares.de
www.mutares.com

Press Contact in Germany
CROSS ALLIANCE communication GmbH
Susan Hoffmeister
Phone: +49 89 125 09 0333
E-mail: sh@crossalliance.de
www.crossalliance.de

Press Contact in France
CLAI
Matthieu Meunier
Phone: +33 6 26 59 49 05
E-mail: matthieu.meunier@clai2.com

Press Contact in UK
14:46 Consulting
Tom Sutton
Phone: +44 7796 474940
E-mail: tsutton@1446.co.uk